News | July 15, 2022
Novavax statement on EMA Nuvaxovid label update related to allergic reaction
Novavax’ clinical development program reported no severe allergic reactions
Novavax’ clinical development program reported no severe allergic reactions
.jpg)
Evonik's six innovation growth fields are: Sustainable nutrition, healthcare solutions, advanced food ingredients, membranes, cosmetic solutions, and additive manufacturing
We see significant potential in working with oncolytic virus companies and Neo antigen-companies
During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
The company also raised Rs 270 crore investment from Temasek in 2019
Saumen is a postgraduate in management from IIM, Ahmedabad and an executive fellow in management from ISB, Hyderabad
This partnership expands DNA Script’s footprint and provides sales and support for the SYNTAX System DNA printer in labs in India
Cedars-Sinai Medical Center Surgeon and Surgical Innovation Officer Dr. Jain joins the venture fund to bring clinical expertise to a portfolio of budding seed-stage healthcare companies
An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines
Aveir VR is specifically designed to be retrieved when therapy needs to evolve or the device needs to be replaced
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)